跳至主要内容
临床试验/NCT03402711
NCT03402711Unknown不适用

Registry of Bleeding Risk in Real World Chinese Acute Coronary Syndrome Patients-II

Chinese PLA General Hospital1 个研究点 分布在 1 个国家目标入组 5,500 人开始时间: 2017年12月14日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
5,500
试验地点
1
主要终点
the incidence of major bleeding during each visit

研究概览

简要总结

The present study was designed to observe the incidence of bleeding events and characteristics of bleeding and exploratively analyse bleeding related biomarkers and gene polymorphisms in ACS patients undergoing PCI.

详细描述

Acute coronary syndrome (ACS) is a group of clinical syndromes characterized by rupture or erosion of coronary atherosclerotic plaques secondary to complete or incomplete thrombus formation.

With the development of antithrombotic drugs and percutaneous coronary interventional therapy, bleeding has become one of the major complications for ACS patients after PCI.Moreover,Bleeding after PCI therapy significantly increased short-term and long-term risk of death.

However, there is a lack of data on the risk of bleeding in ACS patients treated with PCI in the clinical reality world of china.

Therefore,the present study was designed to observe the incidence of bleeding events and characteristics of bleeding and exploratively analyse bleeding related biomarkers and gene polymorphisms in ACS patients undergoing PCI.

The present study was designed to observe the incidence of bleeding events and characteristics of bleeding and exploratively analyse bleeding related biomarkers and gene polymorphisms in ACS patients undergoing PCI.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age≥18 years, male or female;
  • confirmed acute coronary syndrome patients;
  • undergo percutaneous coronary intervention (PCI) treatment;
  • agree to participate in this clinical study and sign a written consent form.

排除标准

  • ACS admission deemed secondary to other cause such as traffic accidents, trauma, severe upper gastrointestinal bleeding, surgery, or procedure;
  • patients who are not intend to attend 1 year of follow-up study or investigators find that patients are not able to comply with the study's requirements;
  • pregnant women or lactating women;
  • investigators consider patients who were not suitable for participation with other reasons

结局指标

主要结局

the incidence of major bleeding during each visit

时间窗: 12 months

Bleeding definition:According to the bleeding Academic Research Congress (BARC) standard;

次要结局

  • the incidence of major adverse cardiovascular events during each visit(12 months)

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yun Dai Chen

Director of the Cardiovascular Department

Chinese PLA General Hospital

研究点 (1)

Loading locations...

相似试验

Registry of Bleeding Risk in Real World Chinese... | 临床试验